(144) found a significant increase in the ratio of CD+8 T/Tregs at mock metastatic sites, following ablative treatment of primary tumor foci, and a greatly enhanced capacity by tumor-infiltrating lymphocytes (TILs) to secrete IFN-γ and TNF-α in mouse models of colon cancer and melanoma. The gene discussed is CTLA4; the disease is neoplasm.